Page 1
Among the greatest strengths of the Head and Neck Surgery Division is our expertise in the evaluation and management of thyroid and parathyroid disorders. Our advances—particularly in ultrasound-assisted diagnostic procedures, surgery, and nonsurgical treatments—are unparalleled. Lisa Orloff, MD, heads our thyroid and parathyroid program, working closely with colleagues Chris Holsinger, MD, and John Sunwoo, MD. Dr. Orloff’s contributions to the field of endocrine head and neck surgery have been significant. She is a pioneering researcher and practitioner in the applications of ultrasound in thyroid and parathyroid care. Her renowned work has helped bring us to the cusp of a new era of incorporating ultrasound into the practice of head and neck surgery. More surgeons now recognize its value in the examination and treatment of tumors and diseases of the salivary gland; examination of the tongue and airway in sleep surgery; tattooing, as an alternative to wire localization, to guide precise surgery; and a myriad of other applications. Ultrasound is especially valuable in pediatric cases, since it is non-invasive, uses no radiation, requires no sedation, and can be performed in the office. Dr. Orloff’s research and practice have demonstrated how ultrasound can improve patient care, decrease costs, and decrease radiation exposure in patients who have head or neck cancer. She is a former Fulbright scholar, and is a voting member of the Food and Drug Administration (FDA) panel to evaluate medical devices for otolaryngology. Dr. Orloff was our nation’s first head and neck surgeon to earn accreditation by the American Institute of Ultrasound in Medicine, and is now a member of the committee for the accreditation of physicians practicing ultrasound in head and neck surgery.